Clorox (NYSE:CLX) COO Sells $1,861,774.98 in Stock

Key Points

• Clorox COO Eric Reynolds sold 15,041 shares of the company's stock for a total of $1,861,774.98, reducing his ownership by 21.72% to 54,221 shares.
• The company's stock price recently declined by 0.9%, reaching $125.88, amid a market cap of $15.40 billion.
• Clorox announced an increase in its quarterly dividend to $1.24, up from the previous $1.22, representing a 3.9% yield on an annualized basis.

The Clorox Company (NYSE:CLX - Get Free Report) COO Eric Reynolds sold 15,041 shares of the business's stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares of the company's stock, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Clorox Stock Down 0.9%

CLX traded down $1.15 during midday trading on Monday, reaching $125.88. 1,959,576 shares of the company were exchanged, compared to its average volume of 1,674,402. The company has a market cap of $15.40 billion, a price-to-earnings ratio of 19.31, a price-to-earnings-growth ratio of 1.02 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company's fifty day moving average price is $124.17 and its 200 day moving average price is $133.21. The Clorox Company has a one year low of $116.53 and a one year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox's quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the company posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th were issued a $1.24 dividend. This is a boost from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 annualized dividend and a dividend yield of 3.9%. The ex-dividend date of this dividend was Wednesday, August 13th. Clorox's dividend payout ratio is currently 76.07%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of CLX. Sonora Investment Management Group LLC boosted its position in Clorox by 2.5% in the 1st quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company's stock valued at $433,000 after buying an additional 72 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in Clorox by 0.6% during the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company's stock valued at $1,953,000 after acquiring an additional 73 shares during the last quarter. Horizon Investments LLC lifted its position in Clorox by 4.4% during the first quarter. Horizon Investments LLC now owns 1,768 shares of the company's stock valued at $258,000 after acquiring an additional 75 shares during the last quarter. Sfmg LLC lifted its position in Clorox by 2.8% during the first quarter. Sfmg LLC now owns 2,780 shares of the company's stock valued at $409,000 after acquiring an additional 76 shares during the last quarter. Finally, Hancock Whitney Corp increased its stake in Clorox by 4.3% during the 1st quarter. Hancock Whitney Corp now owns 2,064 shares of the company's stock valued at $304,000 after purchasing an additional 86 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

CLX has been the topic of several research analyst reports. Citigroup reiterated a "neutral" rating and issued a $135.00 price objective (down previously from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Barclays reduced their price objective on Clorox from $129.00 to $119.00 and set an "underweight" rating on the stock in a research note on Tuesday, July 15th. UBS Group dropped their target price on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a report on Thursday, July 17th. Jefferies Financial Group dropped their target price on shares of Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a report on Thursday, June 26th. Finally, Morgan Stanley lowered their price objective on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. One equities research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of "Reduce" and a consensus price target of $142.18.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.